Article

Ophthalmologists face several public policy issues, AAO official says

When the Centers for Medicare and Medicaid Services (CMS) publishes reports on the physicians who participate in the Physician Quality Reporting Initiative, patients may be suspicious of physicians who don?t participate, said William Rich III, MD, medical director of health policy, American Academy of Ophthalmology (AAO). He provided the perspective of the practitioner during a mini-symposium on glaucoma public policy.

When the Centers for Medicare and Medicaid Services (CMS) publishes reports onthe physicians who participate in the Physician Quality Reporting Initiative, patients may besuspicious of physicians who don't participate, said William Rich III, MD, medical director ofhealth policy, American Academy of Ophthalmology (AAO). He provided the perspective of thepractitioner during a mini-symposium on glaucoma public policy.

He also said that the transactional approach to health care, wherein a physician provides aservice and then is paid, is changing to a system that recognizes efficiency in care.

The drive for enhanced quality measures with an emphasis on outcomes is here to stay, Dr. Richsaid. Any system measuring quality and outcomes, however, be it in the public or privatesector, should recognize (in the case of eye care) that some ophthalmologists aresubspecialists for whom the majority of patients have more serious conditions than those seenby general ophthalmologists or optometrists. Not all systems have this ability right now, headded.

"We have to get consumer groups involved," Dr. Rich said.

The public policy issues related to glaucoma that Dr. Rich addressed included the use ofeconomic profiling, the overvaluation of services, the search for a new fix for the sustainablegrowth rate, the increased scrutiny of new devices, and relations with industry. On the latterpoint, Dr. Rich said, ophthalmologists should examine their individual relationships withindustry. Pressure to report the receipt of meals, drug samples, pens, and the like, isincreasing, he said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.